Remove Branding Remove Office Remove Partnerships
article thumbnail

Done Deal: Organon Completes Acquisition of Dermavant

The Dermatology Digest

“The future of dermatology depends on innovative treatments like VTAMA, and Organon’s acquisition of Dermavant allows us to further expand our existing portfolio of established brands and biosimilar dermatology treatments,” says Kevin Ali, Chief Executive Officer of Organon, in a news release.

article thumbnail

The Brand That Has a “Success Team” To Help Esties Win

Lipgloss and Aftershave

We discovered the Success Team on a tour of the Face Reality acne clinic and corporate office in Danville, CA. The Acne Expert Success Team [Success Team] at Face Reality has a singular focus and that is to help estheticians win!

article thumbnail

The Interplay of Real Estate and Beauty Esthetics

American Esthetician Organization

Being located in residential areas or near office complexes ensures convenience for clients, who often seek beauty services during their free time or after work. Beauty businesses strategically position themselves in areas with a high concentration of residential complexes or office buildings.

article thumbnail

The Interplay of Real Estate and Beauty Esthetics

American Esthetician Organization

Being located in residential areas or near office complexes ensures convenience for clients, who often seek beauty services during their free time or after work. Beauty businesses strategically position themselves in areas with a high concentration of residential complexes or office buildings.

article thumbnail

BioPhotas, Inc.  Makers of Celluma LED Light Therapy Devices Strengthens Management Team

Lipgloss and Aftershave

Cluff Named Chief Executive Officer and Patrick Johnson to Serve as Executive Chairman and Chief Innovation Officer of BioPhotas, Inc. Denise Ryan has been promoted to the position of Chief Clinical Affairs Officer. Wayne (Tony) May has been promoted to Chief Financial Officer and Treasurer. BioPhotas, Inc.,

article thumbnail

Evolus on the Move:  Company Joins Forces With Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe

The Dermatology Digest

and Europe of four unique dermal fillers in late-stage development with anticipated regulatory clearances in the second half of 2024 and commercialization under the brand name Estyme (pronounced “esteem”) fillers in 2025. We are extremely excited to expand our partnership with Evolus beyond the U.S. Evolus, Inc. to now include the U.K.

article thumbnail

Evolus on the Move:  Company Joins Forces With Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe

The Dermatology Digest

and Europe of four unique dermal fillers in late-stage development with anticipated regulatory clearances in the second half of 2024 and commercialization under the brand name Estyme (pronounced “esteem”) fillers in 2025. We are extremely excited to expand our partnership with Evolus beyond the U.S. Evolus, Inc. to now include the U.K.